Intraoperative Ir-192 implantation for early breast cancer. Techniques and results
- Thomas Jefferson Univ. Hospital, Philadelphia, PA (USA)
Patients with early breast cancer (T1-2 N0-1) can be treated by lumpectomy and irradiation with a local control and survival equal to more radical surgery. Between 1982 and 1988, 323 patients with early breast cancer were treated, when possible, with Ir-192 implants at the time of lumpectomy to a local dose of 2000 cGy in 40-50 hours. Ten to 14 days later, the whole breast was treated to 4500 cGy at 180 per fraction in 5 weeks. The 6-year actuarial survival for stages I and II disease was 98% and 91%, respectively, and the recurrence-free survival was 96% and 98%, respectively. When these 323 patients were evaluated by T status, a local control of 97% was the same for T1 and T2 lesions. The cosmetic results were good to excellent in 95% of the patients. This approach has improved our ability to accurately place the boost dose in the breast.
- OSTI ID:
- 6717140
- Journal Information:
- Cancer (Philadelphia); (USA), Vol. 66:1; ISSN 0008-543X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Conservative management of operable breast cancer. Ten years experience at the Foundation Curie. [Gamma radiation]
Impact of radiotherapy technique on the outcome of early breast cancer treated with conservative surgery: A multicenter observational study on 1,176 patients
Related Subjects
MAMMARY GLANDS
NEOPLASMS
RADIOTHERAPY
FRACTIONATED IRRADIATION
IRIDIUM 192
MAN
PATIENTS
RADIATION DOSES
RADIATION SOURCE IMPLANTS
SURGERY
SURVIVAL CURVES
ANIMALS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
BODY
DAYS LIVING RADIOISOTOPES
DISEASES
DOSES
ELECTRON CAPTURE RADIOISOTOPES
GLANDS
HEAVY NUCLEI
IMPLANTS
INTERNAL CONVERSION RADIOISOTOPES
IRIDIUM ISOTOPES
IRRADIATION
ISOMERIC TRANSITION
ISOTOPES
MAMMALS
MEDICINE
NUCLEAR MEDICINE
NUCLEI
ORGANS
PRIMATES
RADIATION SOURCES
RADIOISOTOPES
RADIOLOGY
THERAPY
VERTEBRATES
550601* - Medicine- Unsealed Radionuclides in Diagnostics
550600 - Medicine